Abylaikhan Sharmenov

Dr. Abylaikhan Sharmenov

Department HBP Surgery and Liver Transplantation, National Research Oncology Center, Nur-Sultan, Astana, Kazakhstan
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2021 in Annals of Transplantation
Verified
Journal Article
Open access
PDF file
JSJamilya Saparbay
Jamilya Saparbay
JSJanat Spatayev
Janat Spatayev
ASAbylaikhan Sharmenov
Abylaikhan Sharmenov
SAShokan Aytbayev
Shokan Aytbayev
AUAizhan Uristenova
Aizhan Uristenova
AZAsan Zhexembayev
Asan Zhexembayev
BACKGROUND:Liver transplantation is considered to be the best available treatment option for patients with liver failure. In Kazakhstan, the liver transplantation program was established a decade ago. In this study, we analyzed a low-volume transplant center experience of liver transplantation in Kazakhstan. MATERIAL AND METHODS:Clinical data of the 64 consecutive liver transplantations from deceased and living donors between 2010 and 2020 were retrieved from electronic records. All data were retrospectively analyzed. RESULTS:A total of 64 liver transplantations, 11 from deceased donors and 53 from living donors, were carried out in our center between 2010 and 2020. The mean age of the recipient was 44 years, 53% were female, and 47% were male. Hepatitis B+hepatitis D infection was the most common cause of end-stage liver disease (21 cases; 32.8%). The overall patient survival rates for 1, 3, and 5 years were 75%, 69.5%, and 59.6%, respectively, for recipients of a liver transplant from a living donor and 54.5%, 45.5%, and 39% for recipients of a liver transplant from a deceased donor. CONCLUSIONS:Our clinical outcomes had a high rate of biliary and vascular complications that led to a low survival rate of the recipients. Starting the transplant program in Kazakhstan faced various challenges. In the early period, most transplantations were performed in collaboration with or under the guidance of transplant teams from Russia, Turkey, and South Korea. Improving surgical techniques and protocols of pre- and posttransplantation management could reduce the complications after transplantation.

4 April 2026 in Cancer Treatment and Research Communications
Verified
Journal Article
Open access
AСAytbayev Сhokhan
Aytbayev Сhokhan
JSJamilya Saparbay
Jamilya Saparbay
ZAZhumukov Assylmurat
Zhumukov Assylmurat
ASAbylaikhan Sharmenov
Abylaikhan Sharmenov
ZSZhanat Spatayev
Zhanat Spatayev
ZBZhandos Burkitbayev
Zhandos Burkitbayev
Whipple procedure is a most common performed surgery in patients with benign and malignant tumors of pancreas and periampullary region. There is a scarce of data regarding Whipple procedure outcomes in Kazakhstan. The aim of this study was to analyze Whipple procedure outcomes.All Whipple procedures,performed between 2019 and 2023 in National Research Oncology Center, Astana.Data regarding patients were retrieved from electronic records. 97 patients underwent Whipple procedure for malignant tumor. POPF was the most frequent complication after PD. The 1,2,3-year survivals were 83 %,65 % and 48 % respectively. Median survival after Whipple procedure in our study was 20.5 month (95 % CI 18.2-24.0). Surgery remains the only curative treatment method for patients with pancreatic cancer. POPF occurrence was the most common complication and was higher in comparison to other studies. Our findings demonstrate that the modified Blumgart and Dunk anastomosis with duct-to-mucosa suturing significantly reduce the occurrence of postoperative pancreatic fistula. It can be concluded that first 4 year of experience showed comparable learning curve and further improvement in surgical technique and patient selection can decrease morbidity and mortality rate after pancreatoduodenectomy.

20 January 2025 in Clinical Transplantation and Research
Verified
Journal Article
Open access
PDF file
JSJamilya Saparbay
Jamilya Saparbay
ASAbylaikhan Sharmenov
Abylaikhan Sharmenov
AZAssylmurat Zhumukov
Assylmurat Zhumukov
ARArina Razmazina
Arina Razmazina
CAChokhan Aytbayev
Chokhan Aytbayev
AMAdilbek Mukazhanov
Adilbek Mukazhanov
Jamilya Saparbay, Abylaikhan Sharmenov, Assylmurat Zhumukov, Arina Razmazina, Chokhan Aytbayev, Zhanat Spatayev, Adilbek Mukazhanov. Clin Transplant Res -0001;0:. https://doi.org/10.4285/ctr.24.0050

31 March 2026 in Annals of Transplantation
Verified
Journal Article
Open access
JSJamilya Saparbay
Jamilya Saparbay
ASAbylaikhan Sharmenov
Abylaikhan Sharmenov
CAChokhan Aytbayev
Chokhan Aytbayev
AZAssylmurat Zhumukov
Assylmurat Zhumukov
BYBekkhozha Yeskendirov
Bekkhozha Yeskendirov
ZBZhandos Burkitbayev
Zhandos Burkitbayev
BACKGROUND Liver transplantation (LT) is the definitive treatment for selected patients with end-stage liver disease (ESLD), yet postoperative complications remain a major challenge, particularly in regions where living donor liver transplantation (LDLT) predominates. This study aimed to evaluate surgical outcomes, identify predictors of early mortality, and assess the incidence and impact of biliary complications in a low-volume transplant center in Central Asia. MATERIAL AND METHODS We retrospectively analyzed 113 liver transplantations performed at the National Research Oncology Center between 2013 and 2025. The cohort comprised 88 LDLT (77.9%) and 25 deceased donor LT (DDLT) cases, with a mean recipient age of 43.8 years. RESULTS The overall 1-, 3-, 5-, 7-, and 10-year survival rates were 76.3%, 72.9%, 70.0%, 70.0%, and 70.0%, respectively, with no significant difference between LDLT and DDLT. Biliary leakage (BL) and biliary stricture (BS) occurred in 26.5% and 20% of recipients, respectively. Graft steatosis and external bile duct (EBD) stenting were independent predictors of BL, while intraoperative bleeding and EBD predicted BS. Hepatic artery thrombosis (HAT) occurred in 14.1% of patients and was a significant predictor of 90-day mortality. Sepsis was the strongest predictor of 30-day (OR 7.92, P=0.022) and 90-day mortality (OR 20.1, P CONCLUSIONS Biliary complications remain common, particularly in LDLT, and are influenced by graft and reconstruction factors. Advances in surgical technique, infection control, and early recognition of vascular complication remain decisive for optimizing outcomes after liver transplantation.

JSJamilya Saparbay
Jamilya Saparbay
ZSZhanat Spatayev
Zhanat Spatayev
ASAbylaikhan Sharmenov
Abylaikhan Sharmenov
AZAssylmurat Zhumukov
Assylmurat Zhumukov
CAChokhan Aytbayev
Chokhan Aytbayev
AZAssan Zhexembayev
Assan Zhexembayev
Background: Kazakhstan is among the most highly endemic countries for hepatic echinococcosis worldwide, yet no study systematically characterised the national hepatobiliary surgical burden of cystic (CE) and alveolar (AE) echinococcosis using administrative health data. Methods: National operative data from the Guaranteed Volume of Free Medical Care (GOBMP) and Compulsory Social Health Insurance (OSHI) Systems (1 January 2023–31 December 2025) were combined with institutional case series from the National Research Oncology Center (NROC), Astana (2021–2025). Cases were identified using ICD-10 diagnosis codes and ICD-9-CM procedure codes. Regional and species-specific differences in surgical approach were assessed using Pearson’s chi-square test; continuous variables were compared using the Mann–Whitney U test. Results: A total of 143 hepatic echinococcosis surgeries were performed nationally over the three-year period, with a 12.8% increase in annual volume (47 in 2023, 43 in 2024, 53 in 2025), though this year-to-year variation was not statistically significant (χ2 = 1.06, df = 2, p = 0.59). CE accounted for 74.8% of cases (n = 107), AE for 18.9% (n = 27), and unspecified hepatic echinococcosis for 6.3% (n = 9); the proportion of AE rose from 17.0% in 2023 to 26.4% in 2025. Astana performed 46.2% of all operations nationally, with its share increasing from 34.0% to 58.5% over the study period; together with Almaty, it accounted for 92.6% of all AE cases. Partial hepatic resection was the predominant procedure overall (81.1%), while AE was managed exclusively by resectional or lobar procedures (χ2 = 15.37, p = 0.004), with no percutaneous approaches used. In the NROC case series (n = 63), AE patients were older (median 43.5 vs. 33 years, p = 0.036) and had longer postoperative hospital stays (median 12 vs. 10 days, p = 0.015) than CE patients. Conclusions: Surgical management of hepatic echinococcosis in Kazakhstan is increasingly centralised in Astana and Almaty, with AE consistently requiring more extensive resectional surgery and greater healthcare resource use than CE. These findings support the development of a national echinococcosis registry and formal referral pathways to guide resource allocation and surgical planning.